Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Manic syndrome in AIDS.

K Kieburtz1, A E Zettelmaier, L Ketonen

  • 1Department of Neurology, University of Rochester School of Medicine, NY 14642.

The American Journal of Psychiatry
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Nature aging·2026
Same author

A new methodology for kerogen maturity estimation based on Raman spectroscopy and chemometric analysis.

The Science of the total environment·2023
Same author

Central Nervous System and Head and Neck Histiocytoses: A Comprehensive Review on the Spectrum of Imaging Findings.

Neurographics (2011)·2018
Same author

Clinical approaches to the development of a neuroprotective therapy for PD.

Experimental neurology·2017
Same author

Dynamic contrast-enhanced perfusion processing for neuroradiologists: model-dependent analysis may not be necessary for determining recurrent high-grade glioma versus treatment effect.

AJNR. American journal of neuroradiology·2014
Same author

Pooled analysis of phase III with entacapone in Parkinson's disease.

Acta neurologica Scandinavica·2014

Manic syndrome in patients with Acquired Immunodeficiency Syndrome (AIDS) appears secondary to Human Immunodeficiency Virus (HIV) infection. This condition often co-occurs with cognitive impairment.

Area of Science:

  • Neuropsychiatry
  • Infectious Diseases
  • Neurology

Background:

  • Acquired Immunodeficiency Syndrome (AIDS) is a chronic, life-threatening condition caused by the Human Immunodeficiency Virus (HIV).
  • Neurological and psychiatric complications are increasingly recognized in individuals with HIV/AIDS.
  • The presentation of manic syndromes in the context of HIV infection requires further investigation.

Purpose of the Study:

  • To describe and analyze a series of manic syndrome cases in patients diagnosed with AIDS.
  • To investigate the potential link between HIV infection and the development of manic symptoms.
  • To assess the presence and nature of cognitive impairment in these patients.

Main Methods:

  • Clinical case series involving eight patients with AIDS.

Related Experiment Videos

  • Comprehensive evaluation including clinical assessment, neuropsychological testing, laboratory analyses, and magnetic resonance imaging (MRI).
  • Epidemiological data collection and analysis.

    • Main Results:

    • Eight patients with AIDS presented with a distinct manic syndrome.
    • Evidence from clinical, neuropsychological, laboratory, and imaging data suggests HIV infection as the cause.
    • All patients exhibited concurrent cognitive impairment alongside the manic syndrome.

    Conclusions:

    • The observed manic syndrome is likely secondary to HIV infection in patients with AIDS.
    • HIV-related neurological damage may manifest as psychiatric disorders, including mania.
    • Co-occurring cognitive impairment is a significant feature in this patient population, highlighting the broad impact of HIV on brain function.